Celularity Inc SEC filings CELU
Celularity Inc has 560 filings in SEC EDGAR's recent list, going back to Nov 5, 2018. Its latest annual report, Form 10-K, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 20, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-Q | Filing | Aug 14, 2026 | Jun 30, 2026 |
| 25-NSE | Delisting notice | Jul 22, 2026 | — |
| NT 10-Q | Filing | May 15, 2026 | Mar 31, 2026 |
| NT 10-K | Filing | Mar 31, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Jan 7, 2026 | — |
| CORRESP | Letter to the SEC | Jan 5, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2026 | — |
| EFFECT | Filing | Dec 29, 2025 | — |
| CORRESP | Letter to the SEC | Dec 23, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2025 | — |
| D | Filing | Nov 3, 2025 | — |
| D | Filing | Aug 5, 2025 | — |
| D | Filing | Aug 5, 2025 | — |
| D | Filing | Aug 5, 2025 | — |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| RW | Filing | Mar 10, 2025 | — |
| EFFECT | Filing | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 13, 2025 | — |
| CORRESP | Letter to the SEC | Feb 13, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2025 | — |
| NT 10-Q | Filing | Nov 15, 2024 | Sep 30, 2024 |
| NT 10-Q | Filing | Aug 16, 2024 | Jun 30, 2024 |
| NT 10-Q | Filing | May 15, 2024 | Mar 31, 2024 |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| NT 10-Q | Filing | Nov 14, 2023 | Sep 30, 2023 |
| EFFECT | Filing | Jun 2, 2023 | — |
| CORRESP | Letter to the SEC | May 31, 2023 | — |
| UPLOAD | Letter from the SEC | May 31, 2023 | — |
| NT 10-Q | Filing | May 15, 2023 | Mar 31, 2023 |
| EFFECT | Filing | Aug 23, 2022 | — |
| EFFECT | Filing | Aug 23, 2022 | — |
| EFFECT | Filing | Aug 18, 2022 | — |
| CORRESP | Letter to the SEC | Aug 16, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2022 | — |
| EFFECT | Filing | May 31, 2022 | — |
| UPLOAD | Letter from the SEC | May 27, 2022 | — |
| D | Filing | May 27, 2022 | — |
| CORRESP | Letter to the SEC | May 27, 2022 | — |
| RW | Filing | May 17, 2022 | — |
| EFFECT | Filing | Apr 7, 2022 | — |
| NT 10-Q | Notification of late filing | Aug 16, 2021 | Jun 30, 2021 |
| EFFECT | Filing | Aug 12, 2021 | — |
| CORRESP | Letter to the SEC | Aug 11, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 11, 2021 | — |
| 25-NSE | Delisting notice | Jul 19, 2021 | — |
| 425 | Form 425 | Jul 7, 2021 | — |
| 425 | Form 425 | Jul 1, 2021 | — |
| 425 | Current report | Jun 29, 2021 | — |
| SEC STAFF LETTER | Filing | Jun 25, 2021 | — |
| EFFECT | Filing | Jun 25, 2021 | — |
| CORRESP | Letter to the SEC | Jun 23, 2021 | — |
| 425 | File to disclose information regarding business combinations | Jun 22, 2021 | — |
| CORRESP | Letter to the SEC | Jun 21, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2021 | — |
| 425 | Form 425 | Jun 15, 2021 | — |
| CORRESP | Letter to the SEC | Jun 4, 2021 | — |
| NT 10-Q | Notification of late filing | May 18, 2021 | Mar 31, 2021 |
| 425 | Current report | May 14, 2021 | — |
| 425 | Form 425 | May 14, 2021 | — |
| 425 | Current report | May 10, 2021 | — |
| UPLOAD | Letter from the SEC | May 6, 2021 | — |
| 425 | Current report | May 5, 2021 | — |
| SEC STAFF LETTER | Filing | May 3, 2021 | — |
| 425 | Current report | Apr 30, 2021 | — |
| 425 | Form 425 | Apr 28, 2021 | — |
| CORRESP | Letter to the SEC | Apr 23, 2021 | — |
| 425 | Form 425 | Apr 21, 2021 | — |
| 425 | Form 425 | Apr 20, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2021 | — |
| 425 | Form 425 | Apr 13, 2021 | — |
| 425 | Form 425 | Apr 9, 2021 | — |
| CORRESP | Letter to the SEC | Mar 29, 2021 | — |
| 425 | Current report | Mar 18, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 22, 2021 | — |
| 425 | Form 425 | Feb 11, 2021 | — |
| 425 | Filing | Feb 2, 2021 | — |
| 425 | Form 425 | Feb 1, 2021 | — |
| 425 | Current report | Jan 8, 2021 | — |
| CERT | Filing | May 21, 2019 | — |
| EFFECT | Filing | May 20, 2019 | — |
| 8-A12B | Registration of certain classes of securities | May 17, 2019 | — |
| CORRESP | Letter to the SEC | May 16, 2019 | — |
| CORRESP | Letter to the SEC | May 16, 2019 | — |
| CORRESP | Letter to the SEC | Apr 26, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2019 | — |
| DRSLTR | Filing | Mar 28, 2019 | — |
| DRS/A | Filing | Mar 28, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 29, 2018 | — |
| DRS | Filing | Nov 5, 2018 | — |
Showing 89 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CELU (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Florham Park, NJ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1752828
- Former names
- GX Acquisition Corp. (until Jul 19, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.